FDA inspection
HP Halden Pharma AS: FDA inspection ending May 10, 2023
FDA inspection 1205610 · Voluntary Action Indicated (VAI) · Halden
Key facts
| Inspection ID | 1205610 |
|---|---|
| Firm | HP Halden Pharma AS |
| FEI number | 3002608066 |
| Address | Svinesundsveien 80 |
| City | Halden |
| Country | Norway |
| Fiscal year | 2023 |
| Inspection end date | May 10, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data